BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1088100)

  • 21. Outbreak of cholera caused by Vibrio cholerae 01 intermediately resistant to norfloxacin at Malda, West Bengal.
    Bhattacharya MK; Ghosh S; Mukhopadhyay AK; Deb A; Bhattacharya SK
    J Indian Med Assoc; 2000 Jul; 98(7):389-90. PubMed ID: 11143861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vibrio cholerae resistant to 2,4-diamino-6,7-diisopropylpteridine (O/129) isolated from patients with enteritis in Ceará, Brazil.
    Hofer E; Reis EM; Quintaes BR; Rodrigues DP; Feitosa IS; Angelo MR; Ribeiro LH
    J Health Popul Nutr; 2001 Mar; 19(1):39-42. PubMed ID: 11394182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sensitivity of vibrio El Tor strains to a variety of antibacterial agents.
    Adibfar P
    J Trop Med Hyg; 1974 Jul; 77(7):159-62. PubMed ID: 4424136
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antibiotic sensitivity of Vibrio cholerae 01 isolated from environmental objects].
    Khaĭtovich AB; Ved'mina EA
    Antibiot Khimioter; 1992 Feb; 37(2):20-3. PubMed ID: 1387519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of V. cholerae strains isolated in Bombay.
    Saraswathi K; Deodhar LP
    J Postgrad Med; 1990 Jul; 36(3):128-30. PubMed ID: 2102910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibiotic sensitivity of Vibrio cholerae 01 isolated from humans].
    Khaĭtovich AB
    Antibiot Khimioter; 1998; 43(3):14-8. PubMed ID: 9606491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibiotic resistance of strains of Vibrio cholerae eltor isolated in Douala (Cameroon)].
    Garrigue GP; Ndayo M; Sicard JM; Fonkoua MC; Lemao G; Durand JP; Dodin A
    Bull Soc Pathol Exot Filiales; 1986; 79(3):305-12. PubMed ID: 3769118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transition of drug susceptibilities of Vibrio cholerae O1 in Lao People's Democratic Republic.
    Phantouamath B; Sithivong N; Sisavath L; Munnalath K; Khampheng C; Insisiengmay S; Higa N; Kakinohana S; Iwanaga M
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):95-9. PubMed ID: 11485103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determination of the sensitivity of NAG-Vibrio to antibiotics by the methods of serial dilution in agar and agar diffusion].
    Givental' NI; Razvykh VM; Ved'mina EA; Ogneva NS; Bogdanova LF
    Antibiotiki; 1982; 27(12):18-22. PubMed ID: 7165291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups.
    Chandrasekhar MR; Krishna BV; Patil AB
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1092-7. PubMed ID: 19062701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Variability of Vibrio cholerae as affected by subbacteriostatic concentrations of antibiotics].
    Andrusenko IT; Ved'mina EA; Givental' NI; Pasternak NA; Aleksandrova IK
    Antibiotiki; 1984 Oct; 29(10):770-5. PubMed ID: 6508252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The chemosensitivity of strains of Vibrio cholerae group O1 isolated in Romania between 1977-1995].
    Israil A; Năcescu N; Cedru C; Balotescu C
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(4):213-20. PubMed ID: 9586330
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasmid profiles and antimicrobial susceptibility patterns of Vibrio cholerae O1 strain isolated during a recent outbreak in Nigeria.
    Olukoya DK; Ogunjimi AA; Abaelu AM
    J Diarrhoeal Dis Res; 1995 Jun; 13(2):118-21. PubMed ID: 7594312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibiotic susceptibility of Vibrio cholerae 01: evolution after prolonged curative and preventive use during the 2004 cholera epidemics in Douala (Cameroon)].
    Guévart E; Solle J; Mouangue A; Noeske J; Bita A; Fonkoua MC; Ndayo Wouafo M
    Med Mal Infect; 2006 Jun; 36(6):329-34. PubMed ID: 16757139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [NAG vibrio sensitivity to antibiotics].
    Andrusenko IT; Aleksandrova IK; Ermolov VI; Varegina IZ; Krylova IA
    Antibiotiki; 1982 Feb; 27(2):126-9. PubMed ID: 7065646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The status of antibiotic sensitivity of Vibrio cholerae 0:1 in Ecuador].
    Aldighieri S; Vela E; Pesantes C
    Med Trop (Mars); 1997; 57(1):98. PubMed ID: 9289622
    [No Abstract]   [Full Text] [Related]  

  • 37. [Strain of Vibrio cholerae resistant to tetracycline, chloramphenicol, and trimethoprim-sulfamethoxazole].
    Castillo L
    Rev Med Chil; 1992 Jun; 120(6):698. PubMed ID: 1341805
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of media with antibiotics for isolating resistant forms of the cholera vibrios].
    Libinzon AE; Bogdanova MI; Gol'dberg AM
    Antibiotiki; 1976 Feb; 21(2):141-4. PubMed ID: 776072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry.
    Vijayalakshmi N; Rao RS; Badrinath S
    Epidemiol Infect; 1997 Aug; 119(1):25-8. PubMed ID: 9287939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic sensitivity of strains of nonagglutinating vibrios and El Tor vibrios].
    Ziiaev ShI; Dzhalilov KD; Satybaldieva NSh
    Antibiotiki; 1979 Feb; 24(2):105. PubMed ID: 155421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.